This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Bayeraktiengesellschaft. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Heino Stass: Innovator in Medicament Formulation
Introduction
Heino Stass is a notable inventor based in Cologne, Germany. He is recognized for his contributions to the field of pharmaceutical formulations, particularly in the development of drug formulations that ensure a controlled release of active agents.
Latest Patents
Stass holds a patent for a medicament formulation that features a controlled release of an active agent. The invention relates to drug formulations that comprise 1-cyclopropyl-7-([S,S]-2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quino-lonecarboxylic acid and/or pharmaceutically tolerable salts thereof and/or hydrates thereof as the active compound. This formulation is designed to release the active compound at a defined release rate, enhancing its therapeutic efficacy.
Career Highlights
Throughout his career, Heino Stass has worked with prominent companies in the pharmaceutical industry, including Bayer Aktiengesellschaft and Bayer Healthcare Aktiengesellschaft. His work has significantly impacted the development of innovative drug delivery systems.
Collaborations
Stass has collaborated with esteemed colleagues such as Stefan Kettelhoit and Hans-Martin Siefert, contributing to advancements in pharmaceutical research and development.
Conclusion
Heino Stass is a distinguished inventor whose work in medicament formulation has paved the way for improved drug delivery systems. His innovative approach continues to influence the pharmaceutical industry.